Skip to main content

Drug Testing

Positive tests for non-prescribed use of fentanyl and opioids, as well as heroin, increased during the early months of the COVID-19 pandemic, according to a recently published study of nearly 900,000 de-identified lab results conducted by Quest Diagnostics. Use of fentanyl in combination with other drugs also surged.
A Millennium Health analysis of urine drug test results for non-prescribed fentanyl, cocaine, heroin and methamphetamine before and after COVID-19 was declared a national emergency found all four substances have had double-digit percentage increases in positivity.
At-home testing solutions draw interest as providers look to maintain quality of care while reducing the need for in-person patient visits.
Isotonitazene, a new synthetic opioid that is not detected in standard toxicology screenings, has been linked to deaths in Ohio, Indiana and Illinois, according to a Cincinnati Enquirer report.
A discovery by chemists at UCLA could pave the way for the development of a small, electronic marijuana breathalyzer
Back to Top